Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2005 | 1 |
2006 | 3 |
2007 | 1 |
2008 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia.
Anticancer Drugs. 2008 Aug;19(7):705-12. doi: 10.1097/CAD.0b013e328304ae19.
Anticancer Drugs. 2008.
PMID: 18594212
Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro.
Budman DR, Tai J, Calabro A.
Budman DR, et al.
Breast Cancer Res Treat. 2007 Jul;104(1):93-101. doi: 10.1007/s10549-006-9395-5. Epub 2006 Sep 27.
Breast Cancer Res Treat. 2007.
PMID: 17004104
Item in Clipboard
Identification of potentially useful combinations of epidermal growth factor receptor tyrosine kinase antagonists with conventional cytotoxic agents using median effect analysis.
Budman DR, Soong R, Calabro A, Tai J, Diasio R.
Budman DR, et al.
Anticancer Drugs. 2006 Sep;17(8):921-8. doi: 10.1097/01.cad.0000224457.36522.60.
Anticancer Drugs. 2006.
PMID: 16940802
Item in Clipboard
Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
Budman DR, Calabro A.
Budman DR, et al.
Oncology. 2006;70(2):147-53. doi: 10.1159/000093006. Epub 2006 Apr 26.
Oncology. 2006.
PMID: 16645328
Item in Clipboard
Review: tubulin function, action of antitubulin drugs, and new drug development.
Pellegrini F, Budman DR.
Pellegrini F, et al.
Cancer Invest. 2005;23(3):264-73. doi: 10.1081/cnv-200055970.
Cancer Invest. 2005.
PMID: 15948296
Review.
Item in Clipboard
Studies of synergistic and antagonistic combinations of conventional cytotoxic agents with the multiple eicosanoid pathway modulator LY 293111.
Budman DR, Calabro A.
Budman DR, et al.
Anticancer Drugs. 2004 Oct;15(9):877-81. doi: 10.1097/00001813-200410000-00008.
Anticancer Drugs. 2004.
PMID: 15457128
Item in Clipboard
Cite
Cite